REMSLEEP HOLDINGS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0105 USD | +5.00% |
|
+9.38% | -32.26% |
| Apr. 16 | REMSleep Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | REMSleep Holdings, Inc. cancelled the transaction announced on September 18, 2023 | CI |
Financials (USD)
| Sales 2022 | 0.32 | Sales 2023 | 0.2 | Capitalization | 22.66M |
|---|---|---|---|---|---|
| Net income 2022 | -1M | Net income 2023 | -1M | EV / Sales 2022 | 52,643,021 x |
| Net cash position 2022 | 1.39M | Net cash position 2023 | 541K | EV / Sales 2023 | 108,552,367 x |
| P/E ratio 2022 |
-9.04
x | P/E ratio 2023 |
-12.7
x | Employees | 2 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 96.36% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +5.00% | ||
| 1 week | +9.38% | ||
| Current month | -15.32% | ||
| 1 month | -17.97% | ||
| 3 months | +0.96% | ||
| 6 months | -25.53% | ||
| Current year | -32.26% |
1 week
0.01
0.01
1 month
0.010.01
Current year
0.000.02
1 year
0.000.02
3 years
0.000.04
5 years
0.000.15
10 years
0.0035.00
| Managers | Title | Age | Since |
|---|---|---|---|
Thomas Wood
CEO | Chief Executive Officer | 77 | 07-06-05 |
Jonathan Lane
CTO | Chief Tech/Sci/R&D Officer | 63 | 18-06-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Thomas Wood
CEO | Chief Executive Officer | 77 | 07-06-05 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 0.0105 | +5.00% | 1,497,766 |
| 24-04-25 | 0.01 | +2.46% | 1,301,735 |
| 24-04-24 | 0.00976 | +11.16% | 624,178 |
| 24-04-23 | 0.00878 | -2.88% | 877,905 |
| 24-04-22 | 0.00904 | -5.83% | 716,152 |
Delayed Quote OTC Markets, April 26, 2024 at 03:58 pm EDT
More quotes
REMSleep Holdings, Inc. is a medical technology company. The Company is focused on the development and commercialization of solutions for patients with obstructive sleep apnea. Its DeltaWave CPAP interface (the DeltaWave), which is a device to treat patients with sleep apnea. The patent-pending DeltaWave product is a nasal-pillow type interface that is designed with airflow characteristics to enable patients with sleep apnea to breathe normally. Its product is manufactured by mold makers. It has molds made in China. Its target market includes sleep product distributors that distribute its product; home care dealers; private sleep labs; product end users; physicians, particularly sleep physicians; medical groups; hospitals, and medical associations, such as the American Academy of Sleep Medicine and the American Sleep Association.
| 1st Jan change | Capi. | |
|---|---|---|
| -32.26% | 15.35M | |
| -2.31% | 187B | |
| -3.20% | 106B | |
| -5.04% | 66.9B | |
| +0.20% | 49.45B | |
| +17.29% | 48B | |
| +4.06% | 40.84B | |
| +2.07% | 26.48B | |
| +2.36% | 26.25B | |
| +12.96% | 24.62B |
- Stock Market
- Equities
- RMSL Stock
